Table 2.

The clinical features of all Guillain-Barré syndrome patients

Demography	GBS group
Symptoms of antecedent infection
None	48/85 (56.5%)
Upper respiratory tract infection	25/85 (29.5%)
Diarrhea	10/85 (11.8%)
Tonsillectomy	1/85 (1.1%)
Upper respiratory tract infection+ diarrhea	1/85 (1.1%)
Cranial nerve involvement	73%
Pain	33.3%
Autonomic dysfunction	11.1%
Respiratory involvement	16.6%
Treatment
Plasma exchange	0
IVIG	45/70 (64.3%)
IVIG and methylprednisolone	11/70 (15.8%)
Methylprednisolone	5/70 (7.1%)
No treatment	9/70 (12.8%)
Outcome
Walking without assistance	59/64 (87.4%)
Death	1/64 (1.5%)

GBS, Guillain-Barré syndrome; IVIg, intravenous immunoglobulin